Hepato-Pancreato-Biliary Surgery
111 – 120 of 176
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Is immunotherapy the holy grail for pancreatic cancer?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Intraductal papillary mucinous carcinoma versus pancreatic ductal adenocarcinoma : A systematic review and meta-analysis
(
- Contribution to journal › Scientific review
-
Mark
Adjuvant therapy in invasive intraductal papillary mucinous neoplasm (IPMN) of the pancreas: a systematic review
(
- Contribution to journal › Scientific review
-
Mark
Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article
- 2018
-
Mark
Intraductal papillary mucinous neoplasms of the pancreas – a cost-effectiveness analysis of management strategies for the branch-duct subtype
(
- Contribution to journal › Article
-
Mark
Significance of poor performance status after resection of colorectal liver metastases
(
- Contribution to journal › Article
-
Mark
Calcium-activated chloride channel regulator 1 as a prognostic biomarker in pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Response "Unresectable Colorectal Liver Metastases: : When Definitions Matter to Appropriately Assess Extreme Liver Resection Techniques"
(
- Contribution to journal › Article
-
Mark
Quantitative Assessment of Urea In-Solution Lys-C/Trypsin Digestions Reveals Superior Performance at Room Temperature over Traditional Proteolysis at 37 °C.
(
- Contribution to journal › Article
-
Mark
ALPPS Improves Resectability Compared with Conventional Two-stage Hepatectomy in Patients with Advanced Colorectal Liver Metastasis : Results from a Scandinavian Multicenter Randomized Controlled Trial (LIGRO Trial)
(
- Contribution to journal › Article